Amy Abernethy, a director of CM Life Sciences III Inc., just received 389,223 options from the company. The strike price of the options received was $3.03, and these expire on February 25, 2032. Abernethy now owns at least 389,223 options on the company.
Some additional info was provided as follows:
This Form 4/A amends and restates the original Form 4 filed on March 1, 2022 (the "Original Form 4"). The number of shares of Common Stock subject to the stock option granted to the Reporting Person on February 25, 2022 was erroneously reported as 449,644 in the Original Form 4.
One-third of the shares underlying this option shall vest and become exercisable on December 17, 2022, with the remainder vesting in eight substantially equal quarterly installments the
reafter, subject to the Reporting Person's continuous service as of each vesting date.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever CM Life Sciences III Inc. makes a similar move, sign up!
